No Data
Express News | Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the Alphabreak Trial Evaluating Fpi-2265 in Metastatic Castration-Resistant Prostate Cancer
Omaha Healthcare Company Fusion Announces Nursing Scholarship Winners
OMAHA, Neb., May 9, 2024 /PRNewswire/ -- Omaha-based healthcare company Fusion is announcing the 10 winners of the Compassion in Care – A Fusion Scholarship, aiming to assist students pursuing their
RBC Capital Remains a Hold on Fusion Pharmaceuticals (FUSN)
Fusion Pharmaceuticals Inc. Grapples With Tax Uncertainty: Potential Impacts on Finances and Investor Trust
Fusion Pharmaceuticals Poised for AstraZeneca Acquisition
Fusion Pharmaceuticals | 10-Q: Quarterly report